The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd

BSE 524518 · NSE KREBSBIO · ISIN INE268B01013 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹56.54

+6.46%

BSE close, 28 August 2026

Market cap

₹121.90 cr

2.2 cr shares · Micro cap

Free float

₹33.18 cr

as published

P/E · P/B

-8.7× · -0.94×

EPS ₹-6.54 · BV ₹-60.15

FY25-26 rev / PAT

23.73 / -16.93

₹ cr, as filed

Filings, window

12

2 selected · 17%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹38.52 52-WK HIGH ₹81.80 ₹56.54 42% of range
Against 52-week high-30.9%
Against 52-week low+46.8%
Day change+6.46%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-6.54
Price / earnings-8.65×
Price / book-0.94×
Book value — derived, price ÷ P/B₹-60.15
Return on equity10.83%
Operating margin14.09%
Net margin-35.58%

Consistency check

P/B ÷ P/E, which must equal ROE
10.87%
ROE as published
10.83%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 6.98 -2.49 -1.15 14.09% -35.58%
Mar-26 · Q 6.81 -2.34 -1.09 16.68% -34.37%
FY25-26 23.73 -16.93 -7.85 -14.43% -71.35%

Quarter on quarter

Revenue, quarter on quarter
+2.5%
Net profit, quarter on quarter
-6.4%
Operating margin, quarter on quarter
-259 bps

Disclosure profile 12 filings in the window

0 median 17.0 p75 · 25 sector max 52 12 29th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM3
Newspaper Publication3
Annual Report1
Board Meeting1
Compliance Certificate1
Trading Window1
Procedural sub-total10
Total12

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

12 filings · 2 selected · busiest 2026-08-06 and 2026-09-04

Filing rhythm · the twelve most recent

2026-07-282026-10-05

SelectedProcedural

Filings

12 in the window · 4 earlier on record

  1. 5 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    The Company has enclosed herewith certificates recived from RTA under reg 74 (5)

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer Report of 34th AGM

    AGM/EGM / AGM View filing →

  3. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 34th AGM

    AGM/EGM / AGM View filing →

  4. 21 September 2026 ·

    Trading Window

    Closure of Trading Window

    The Company has enclosed herewith intimation for closure of trading window for the quarter ended 30.09.2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 7 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    The Company has enclosed herewith copy of Newspaper Advertiesment of the Notice issued to shareholders wrt 34th AGM.

    Company Update / Newspaper Publication View filing →

  6. 4 September 2026 ·

    AGM / EGM

    Notice Of 34Th Annual General Meeting Of The Company

    The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26.

    AGM/EGM / AGM View filing →

  7. 4 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    We are enclosing herewith copy of Annual Report for the financial year ended 31st March 2026.

    Others / Reg. 34 (1) Annual Report View filing →

  8. 3 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    The Company has enclosed herewith copy of newspaper advertiesment w.r.t. prior intimation of 34th AGM of the Company.

    Company Update / Newspaper Publication View filing →

  9. 7 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026

    Company Update / Newspaper Publication View filing →

  10. 6 August 2026 ·

    Results

    Results

    Results for the quarter ended 30602026

    Result / Financial Results View filing →

  11. 6 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

    Board Meeting / Outcome of Board Meeting View filing →

  12. 28 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th Agust 2026

    Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Intimation ....

    Board Meeting / Board Meeting View filing →

RSS feed for Krebs Biochemicals & Industries Ltd · the 50 most recent filings